Classifieds - Sentara Healthcare

Article

Sentara Healthcare, located in Hampton Roads, VA is seeking an Experience RN for a Unit Manager Position on an Oncology Unit. This full-time position is located at Sentara Norfolk General Hospital, the region’s first Magnet Hospital. This level one trauma/teaching hospital is located in Norfolk, VA. The Hematology/Oncology Unit (HOU) is an 18-bed, self-contained unit providing a wide range of oncology services to a variety of diverse patient populations including the newly diagnosed through end of life, with specialties in chemotherapy and peripheral blood stem cell transplant.

Sentara Healthcare, located in Hampton Roads, VA is seeking an Experience RN for a Unit Manager Position on an Oncology Unit. This full-time position is located at Sentara Norfolk General Hospital, the region’s first Magnet Hospital. This level one trauma/teaching hospital is located in Norfolk, VA. The Hematology/Oncology Unit (HOU) is an 18-bed, self-contained unit providing a wide range of oncology services to a variety of diverse patient populations including the newly diagnosed through end of life, with specialties in chemotherapy and peripheral blood stem cell transplant.

 

Education: BSN registered nurse

Experience: Three years RN experience in an Acute Care Setting with Supervisory/Leadership experience with an Oncology/medicine focus

License: Registered Nurse licensed to practice in the Commonwealth of VA

Skills: Knowledge of Oncology Nursing, operations, systems management and HR management experience as well as the ability to lead the staff to provide excellent customer service.

Jobs/Summary Purpose: Serves as mentor by role modeling a professional practice consistent with organizational goals, customer service, clinical effectiveness, and standards of care. Responsible and accountable for daily operations of one or two assigned unit (s) on a twenty-four hour basis – seven days a week. Develops, implements, and monitor compliance to unit operating budget.

 

To apply: www.sentara.com/employment
Keyword search: 28608BR
or for additional information contact:
arlene sadoff at afsadoff@sentara.com

Recent Videos
Investigators are currently evaluating mosunetuzumab in relapsed disease or comparing it with rituximab in treatment-naïve follicular lymphoma.
3 experts in this video
3 experts in this video
Compared with second-generation tyrosine kinase inhibitors, asciminib was better tolerated in patients with chronic myeloid leukemia.
The 2 main pafolacianine components, a folate analog and a dye, are commonly used in other medical applications.
Using bispecific antibodies before or after CAR T-cell therapy in multiple myeloma is an area of education for community oncologists.
Related Content